Prioritizing diversity in polygenic risk prediction of primary open-angle glaucoma

Active Project Grant Awarded Last action

Award ID
R01EY033829
Recipient
Awarding agency
Obligated
$6,319,067

Award facts

Assistance listing
93.867 Vision Research
Completion date 86% complete
Place of performance
Greenville, NC 27858, USA

Award details come from USAspending.gov.

Description

Abstract
Prioritizing diversity in polygenic risk prediction of primary open-angle glaucoma glaucoma is the leading worldwide cause of irreversible blindness. Primary open-angle glaucoma (poag), the most common type of glaucoma, is more prevalent and severe in individuals of african ancestry. Unfortunately, individuals from this ancestral group have been under-represented in genome-wide association studies (gwas) thus far. Furthermore, polygenic risk scores (PRS) based on gwas data from european-descent populations are not transferable to individuals of diverse (non-european) ancestry. Given the aspirations of precision medicine, PRS demonstrate clinical potential but fall short, in part, due to the lack of diversity in these studies. We hypothesize that clinically-implementable PRS can be achieved by including african and african- descent individuals in gene discovery and PRS development. To inform and improve precision ocular health, we will prioritize diversity in polygenic risk prediction of poag with three proposed aims that will yield the largest-ever meta analyses of poag in african and african-descent individuals and the first-ever african-ancestry focused poag PRS. In aim 1, we will perform meta-analyses of 47,078 samples (18,037 cases, 29,041 controls) to identify novel poag loci in african and african-descent populations. Given that most gwas have been performed in mainly european and european-descent populations, we hypothesize that undiscovered poag risk loci will be detected by leveraging the power of meta-analysis of case-control gwas in african and african-descent population samples. In aim 2, we will meta-analyze admixture mapping results for each of our datasets to identify african ancestry-specific poag loci. We hypothesize that admixture mapping will identify genomic regions where african ancestry CO- segregates with poag risk. Significant loci from aims 1 and 2 will be fine-mapped and evaluated for selection signatures. In aim 3, we will build and optimize poag PRS in african and african-descent base dataset meta- analyses. We will then evaluate novel and published PRS for poag classification in test datasets. We hypothesize that ancestrally-informed poag PRS will better predict poag and relevant clinical outcomes in african and african-descent populations compared to those derived from primarily european-descent data. Meta-analysis results from aims 1 and 2 as well as variants from our optimized PRS in aim 3 will undergo pathway analyses to identify biological pathways and statistical driver genes implicated in poag risk. In the long-term, we hope that the information gained from this project will inform a broader understanding of poag genetics across diverse ancestry groups and provide the foundational basis for the clinical applicability of ancestrally-informed PRS for poag.

Transactions

Action Obligated Date
Amendment $681,489
Amendment Optimizing genetic risk models for primary open-angle glaucoma through expanded population genomic analysis - glaucoma is a leading cause of irreversible vision… $688,777
Amendment $59,469
Amendment Optimizing genetic risk models for primary open-angle glaucoma through expanded population genomic analysis - glaucoma is a leading cause of irreversible vision… $59,469
Amendment $920,594
Amendment -$638,677
Amendment -$143,246
Amendment -$138,671
Amendment $920,594
Amendment -$638,677
Amendment -$143,246
Amendment -$138,671
Amendment $0
Amendment $0
Amendment $687,028
Amendment $687,028
Amendment $687,028
Amendment $0
Amendment $0
Amendment $0
Amendment $138,671
Amendment $638,677
Amendment $638,677
Amendment $676,377
Original award $676,377
Show all 25

Subawards

Subrecipient Amount Awarded
Case Western Reserve University Case Western Reserve University' s role on this proposal will be to coordinate local data analyses and delivery of summary statistics and other data output… $491,367
The Trustees Of The University Of Pennsylvania Proposed (draft) statements of work for UPenn, Co-site-PIs Dr. Joan O’Brien and Dr. Shefali Setia Verma (Co-Is on grant proposal): Dr. Joan… $145,586
Kaiser Foundation Hospitals Kaiser PI will work with ECU PI on the design, interpretation of results, and writing of manuscripts. $33,200
Duke University Dr. Hauser has many years of experience in ocular genetics, having published extensively in both glaucoma and age-related macular degeneration. He is an… $165,223
College Of Medicine, University Of Ibadan The University of Ibadan is funded to collect Primary Open Angle Glaucoma (POAG) cases and controls for GWAS analysis. To date, we have collected… $96,728

Quick answers

Who received award R01EY033829?

R01EY033829 was awarded to East Carolina University by National Eye Institute (National Institutes of Health) on July 1, 2022.

How much is award R01EY033829 worth?

$6,319,067 has been obligated on R01EY033829.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award